Specifar Pharmaceuticals S.A.

Specifar is engaged in the development of generic formulations, manufacturing, marketing and sales in Greece. Moreover Specifar offers dossiers and generic finished formulations to its partners via licensing and supply agreements or distribution agreements.

Activity:

- Contract Manufacturing
- Licensing & Business Development
- Manufacturing
- Market Research & Marketing
- Regulatory Affairs & Legal Services
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Devices
- Generics
- FP (finished products)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic targets:

- Allergy
- Alzheimer's Disease
- Asthma
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Gastrointestinal
- Hematology
- Infectious Diseases
- Men's Health
- Neurology
- Pain
- Surgery
- Urology

Markets Covered

a. HeadQuarter: Greece

b. Continent(s) active: Africa , Asia , Australia/New-Zealand , Central/South America , Europe , Near/Middle East , North America

c. Countries active: Europe, Australia, Africa, North America

Corporate data:

Number of Employees: 180

Turnover:

Amount:	Year:	Currency:
25.000.000	2006	Euro

Year founded: 1933